HealthEquity (NASDAQ:HQY - Get Free Report) is anticipated to announce its earnings results after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of $0.71 per share and revenue of $306.12 million for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.
HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the firm earned $0.40 EPS. On average, analysts expect HealthEquity to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
HealthEquity Trading Up 1.3 %
Shares of HealthEquity stock traded up $1.26 during mid-day trading on Tuesday, hitting $95.74. The stock had a trading volume of 888,641 shares, compared to its average volume of 649,958. The firm has a 50-day moving average of $105.75 and a two-hundred day moving average of $94.80. The firm has a market cap of $8.30 billion, a P/E ratio of 87.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity has a 12-month low of $65.01 and a 12-month high of $115.59.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on the stock. Bank of America boosted their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a "neutral" rating and a $108.00 price objective for the company. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. BTIG Research raised their price target on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Finally, JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $113.54.
View Our Latest Research Report on HQY
Insider Activity
In other news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares of the company's stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.20% of the company's stock.
HealthEquity Company Profile
(
Get Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.